Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00624156 · ClinicalTrials.gov registry record
Expressive Writing and Adjustment to Metastatic Breast Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 98
- Enrollment target
NCT00624156: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00624156 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00624156 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
We are doing this study to see if writing about life experiences helps women adjust to breast cancer that has spread. We will compare two groups. One group will write about their breast cancer experience. The other will write about their daily activities. What we learn from this study may help us to find new ways to help women cope with breast cancer that has spread.
Interventions
- BEHAVIORAL Writing Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-01 |
What the finished NCT00624156 record still lists
NCT00624156 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Writing Intervention is the first listed.
NCT00624156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00624156 about?
NCT00624156 is a clinical study titled "Expressive Writing and Adjustment to Metastatic Breast Cancer". We are doing this study to see if writing about life experiences helps women adjust to breast cancer that has spread. We will compare two groups. One group will write about their breast cancer experience. The other will write about their daily activities. What we learn from this study may help us to...
What is the current status of trial NCT00624156?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2008-02. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00624156?
The interventions under investigation include: Writing Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00624156?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia